Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

M Miravitlles, M Ferrer, A Pont, R Zalacain, J L Alvarez-Sala, F Masa, H Verea, C Murio, F Ros, R Vidal, IMPAC Study Group, M Miravitlles, M Ferrer, A Pont, R Zalacain, J L Alvarez-Sala, F Masa, H Verea, C Murio, F Ros, R Vidal, IMPAC Study Group

Abstract

Background: A study was undertaken to evaluate exacerbations and their impact on the health related quality of life (HRQL) of patients with chronic obstructive pulmonary disease (COPD).

Methods: A 2 year follow up study was performed in 336 patients with COPD of mean (SD) age 66 (8.2) years and mean (SD) forced expiratory volume in 1 second (FEV(1)) 33 (8)% predicted. Spirometric tests, questions regarding exacerbations of COPD, and HRQL measurements (St George's Respiratory Questionnaire (SGRQ) and SF-12 Health Survey) were conducted at 6 month intervals.

Results: A total of 1015 exacerbations were recorded, and 103 (30.7%) patients required at least one hospital admission during the study. After adjustment for baseline characteristics and season of assessment, frequent exacerbations had a negative effect on HRQL in patients with moderate COPD (FEV(1) 35-50% predicted); the change in SGRQ total score of moderate patients with > or =3 exacerbations was almost two points per year greater (worse) than those with <3 exacerbations during the follow up (p = 0.042). For patients with severe COPD (FEV(1) <35% predicted) exacerbations had no effect on HRQL. The change in SGRQ total score of patients admitted to hospital was almost 2 points per year greater (worse) than patients not admitted, but this effect failed to show statistical significance in any severity group. There was a significant and independent seasonal effect on HRQL since SGRQ total scores were, on average, 3 points better in measurements performed in spring/summer than in those measured in the winter (p<0.001).

Conclusions: Frequent exacerbations significantly impair HRQL of patients with moderate COPD. A significant and independent effect of seasonality was also observed.

References

    1. Clin Drug Investig. 2003;23(7):439-50
    1. Arch Bronconeumol. 2001 Jul-Aug;37(7):269-78
    1. Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
    1. Am J Respir Crit Care Med. 2001 Jan;163(1):122-8
    1. Eur Respir J. 2002 Feb;19(2):209-16
    1. Am J Respir Crit Care Med. 2000 May;161(5):1608-13
    1. Thorax. 2003 Jul;58(7):589-93
    1. Respir Med. 1999 Mar;93(3):173-9
    1. Lancet. 2004 Feb 21;363(9409):587-93
    1. Respir Med. 2002 Jan;96(1):39-51
    1. Respiration. 2000;67(5):495-501
    1. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22
    1. Am Rev Respir Dis. 1992 Jun;145(6):1321-7
    1. Chest. 2001 Jun;119(6):1661-70
    1. Eur Respir J. 2001 May;17(5):928-33
    1. Eur Respir J. 2002 Mar;19(3):398-404
    1. Chest. 2002 Mar;121(3):688-96
    1. Med Clin (Barc). 1995 May 27;104(20):771-6
    1. Arch Bronconeumol. 2002 Nov;38(11):530-5
    1. Ann Intern Med. 1987 Feb;106(2):196-204
    1. Med Care. 1996 Mar;34(3):220-33
    1. Qual Life Res. 2002 Jun;11(4):329-38
    1. Thorax. 1997 Jan;52(1):67-71
    1. Am J Respir Crit Care Med. 1997 Apr;155(4):1283-9
    1. Chest. 2002 May;121(5):1449-55
    1. Chest. 2000 Oct;118(4):981-9
    1. Clin Drug Investig. 2003;23(6):387-94
    1. Eur Respir J. 1996 Jun;9(6):1160-6
    1. Chest. 1996 Oct;110(4):896-903
    1. Eur Respir J. 2002 Mar;19(3):405-13
    1. N Engl J Med. 2004 Mar 4;350(10):1005-12
    1. Ann Intern Med. 1997 Dec 15;127(12):1072-9
    1. Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅